Antidotes and poisoning medical products / 2024-2025

The Scope of the procurement is Antidotes and poisoning medical products to the rescEU project. The Scope of procurement is described in more detail in the Call for tenders and its Annexes. The procurement is divided in thirteen (13) lots. Tender may be submitted for one or several lots. - LOT 1: Dimercaptopropane sulfonate (DMPS) 100 mg tablets/capsules - LOT 2: Prussian blue, i.e. Iron(III) hexacyanoferrate(II) 500 mg tablets/capsules - LOT 3: Succimer (Dimercaptosuccinic acid, DMSA) 200 mg tablets/capsules - LOT 4: Dimercaptopropane sulfonate (DMPS) 50 mg/ml (5 ml per vial/ampoule) - LOT 5: Calcium trisodium pentetate (Ca-DTPA) 1 g / 5 ml (5 ml per vial/ampoule) - LOT 6: Zinc trinatrium pentetate (Zn-DTPA) 1055 mg / 5 ml (5 ml per vial/ampoule) - LOT 7: Obidoxime 250 mg/ml (1 ml per vial/ampoule) - LOT 8: Pralidoxime 2 g / 100 ml (100 ml per vial/ampoule) - LOT 9: Hydroxocobalamin 5 g (5 g per vial/ampoule) - LOT 10: Fomepizole 5 mg/ml (20 ml per vial/ampoule) - LOT 11: Calcium edetate (Ca-EDTA) 50 mg/ml (10 ml per vial/ampoule) - LOT 12: Calcium gluconate 100 mg/ml (10 ml per vial/ampoule) - LOT 13: Silver sulfadiazine 10 mg/g (50 g - 100 g per tube/container) The contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the contract has been signed by contracting parties and expires when all contractual duties of the contract have been performed. Call for Tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements Annex 2 Contract Annex 3 Security annex Annex 4 Description of the Handi service Annex 5 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 6 Estimated quantity (restricted, TL IV) Annex 7 Confidentiality commitment Please note that the numbering of the annexes differs between the Contract and the Call for Tenders.